This project is fully funded for 4 years by the Guy Dodson Fund for Structural Biology research at York, established in 2013 with a donation from Danish pharmaceutical company, Novo Nordisk. Funding will cover (i) tuition fees at the UK/EU rate, (ii) a tax-free annual stipend at the standard Research Council rate (£14,057 for 2015-2016, typically increases annually in line with inflation) and (iii) a contribution towards research costs. Applications are welcomed from those from the UK and other EU countries.
Menting et al. How insulin engages its primary binding site on the insulin receptor. (2013) Nature, 493, 241-245
Jiracek et al. Implications for the active form of human insulin based on structural convergence of highly active hormone analogues. (2010) PNAS, 107, 1966-1970
FTE Category A staff submitted: 47.06
Research output data provided by the Research Excellence Framework (REF)Click here to see the results for all UK universities